Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 8 years
- Director since
- 2023
8 years of board service in total across 3 boards, counting each seat separately. Longest: NeoGenomics Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Alumis Inc. June 30, 202699.7%
-
NeoGenomics Inc. May 21, 202696.9%
-
NeoGenomics Inc. May 22, 202593.7%
-
Rhythm Pharmaceuticals Inc. September 18, 202487.3%
-
NeoGenomics Inc. May 23, 2024100.0%
-
NeoGenomics Inc. May 25, 2023100.0%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 30, 2026 | Alumis Inc. | Grant or award | +3,553 | — | — |
| Jun 23, 2026 | Rhythm Pharmaceuticals Inc. | Option exercise | +4,712 | — | — |
| Jun 22, 2026 | Rhythm Pharmaceuticals Inc. | Option exercise | +37,000 | $28.27 | $1,045,990 |
| Jun 22, 2026 | Rhythm Pharmaceuticals Inc. | Open-market sale | −37,000 | $100.32 | $3,711,840 |
| Jun 15, 2026 | NeoGenomics Inc. | Open-market sale | −5,307 | $11.10 | $58,908 |
| Jun 9, 2026 | NeoGenomics Inc. | Open-market sale | −5,307 | $11.29 | $59,916 |
| Jun 1, 2026 | NeoGenomics Inc. | Option exercise | +23,077 | — | — |
| Jun 18, 2025 | Rhythm Pharmaceuticals Inc. | Option exercise | +4,000 | — | — |
| Jun 1, 2025 | NeoGenomics Inc. | Option exercise | +12,254 | — | — |
| May 9, 2025 | NeoGenomics Inc. | Open-market purchase | +7,000 | $8.14 | $56,980 |
| Sep 10, 2024 | Rhythm Pharmaceuticals Inc. | Option exercise | +10,000 | $4.15 | $41,500 |
| Sep 10, 2024 | Rhythm Pharmaceuticals Inc. | Option exercise | +7,501 | $18.99 | $142,444 |
| Sep 10, 2024 | Rhythm Pharmaceuticals Inc. | Open-market sale | −8,490 | $49.05 | $416,435 |
| Sep 10, 2024 | Rhythm Pharmaceuticals Inc. | Open-market sale | −8,661 | $50.20 | $434,782 |
| Sep 10, 2024 | Rhythm Pharmaceuticals Inc. | Open-market sale | −350 | $50.60 | $17,710 |
Questions about Lynn A. Tetrault
What boards is Lynn A. Tetrault on?
Lynn A. Tetrault sits on the boards of Alumis Inc., NeoGenomics Inc. and Rhythm Pharmaceuticals Inc.
How long has Lynn A. Tetrault served on boards?
Our records show at least 8 years of board service across 3 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.